Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines

Oncology Research

Volumn 10, Issue 4, 1998, Pages 193-200

  McGuire, John J ^a   Russell, Cynthia A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Antibody; Drug resistance; Folylpolyglutamate synthetase; Methotrexate; Western blot

Indexed keywords

ANTIBODY; FOLIC ACID ANTAGONIST; FOLYLPOLYGLUTAMATE SYNTHASE; METHOTREXATE; PEPTIDE FRAGMENT; PEPTIDE SYNTHASE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG RESISTANCE; DRUG SCREENING; ENZYMOLOGY; HALF LIFE TIME; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; RABBIT; T CELL LEUKEMIA;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FOLIC ACID ANTAGONISTS; HALF-LIFE; HUMANS; LEUKEMIA, T-CELL; METHOTREXATE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE SYNTHASES; RABBITS; TUMOR CELLS, CULTURED;

EID: 0031610120     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Shane, B. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam. Horm. 45: 263-335; 1989.
2. McGuire, J. J.; Hsieh, P.; Bertino, J. R. Enzymatic synthesis of polyglutamate derivatives of 7-hydroxymethotrexate. Biochem. Pharmacol. 33: 1355-1361; 1984.
3. Foo, S. K.; McSloy, R. M.; Rousseau, C.; Shane, B. Folate derivatives in human cells: Studies on normal and 5,10-methylenetetrahydrofolate reductase-deficient fibroblasts. J. Nutr. 112: 1600-1608; 1982.
4. McGuire, J. J.; Mini, E.; Hsieh, P.; Bertino, J. R. Role of methotrexate polyglutamates in methotrexate- and sequential methotrexate-5-fluorouracil-mediated cell kill. Cancer Res. 45: 6395-6400; 1985.
5. Pizzorno, G.; Mini, E.; Caronnelo, M.; McGuire, J. J.; Moroson, B. A.; Cashmore, A. R.; Dreyer, R. N.; Lin, J. T.; Mazzei, T.; Periti, P.; Bertino, J. R. Resistance to methotrexate in CCRF-CEM cells after short-term, high-dose treatment is associated with impaired polyglutamylation. Cancer Res. 48: 2149-2155; 1988.
6. McCloskey, D. E.; McGuire, J. J.; Russell, C. A.; Rowan, B. G.; Bertino, J. R.; Pizzorno, G.; Mini, E. Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines. J. Biol. Chem. 266: 6181-6187; 1991.
7. McGuire, J. J. Antifolate polyglutamylation in preclinical and clinical antifolate resistance. In: Jackman, A. L., ed. Antifolate drugs: Basic research and clinical practice. Totowa, NJ: Humana Press (in press).
8. McGuire, J. J.; Haile, W. H.; Russell, C. A.; Galvin, J. M.; Shane, B. Evolution of resistance in the CCRF-CEM human leukemia cell line following intermittent exposure to methotrexate. Oncol. Res. 7: 535-543; 1995.
9. Garrow, T. A.; Admon, A.; Shane, B. Expression cloning of a human cDNA encoding folylpoly(γ-glutamate) synthelase and determination of its primary structure. Proc. Natl. Acad. Sci. USA 89: 9151-9155; 1992.
10. Devereux, J.; Haeberli, P.; Smithies, O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12: 387-395; 1984.
11. Kyte, J.; Doolittle, R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132; 1982.
12. Tam, J. P. High-density multiple-antigen peptide system for preparation of antipeptide antibodies. Methods Enzymol. 168: 7-15; 1989.
13. Tam, J. P. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA 85: 5409-5413; 1988.
14. Hornbeck, P. Enzyme-linked immunosorbent assays (ELISA). In: Ausubel, F. M.; Brent, R.; Kingston, R. E.; Moore, D. D.; Seidman, J. G.; Smith, J. A.; Struhl, K., eds. Current protocols in molecular biology, vol. 2. New York: Wiley; 1996: 11.2.1-11.2.22.
15. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685; 1970.
16. Ludlow, J. W.; Shon, J.; Pipas, J. M.: Livingston, D. M.; DeCa-prio, J. A. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60: 387-396; 1990.
17. McGuire, J. J.; Hsieh, P.; Coward, J. K.; Bertino, J. R. In vitro methotrexate polyglutamate synthesis by rat liver folylpolyglutamate synthetase and its inhibition by bromosulfophthalein. Adv. Exp. Biol. Med. 163: 199-214; 1983.
18. Foley, G. F.; Lazarus, H.; Farber, S.; Uzman, B. G.; Boone, B. A.; McCarthy, R. E. Continuous culture of lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18: 522-529; 1965.
19. Mini, E.; Srimatkandada, S.; Medina, W. D.; Moroson, B. A.; Carman, M. D.; Bertino, J. R. Molecular and karyological analysis of methotrexate-resistant and-sensitive human leukemic CCRF-CEM cells. Cancer Res. 45: 317-325; 1985.
20. Rosowsky, A.; Lazarus, H.; Yuan, G. C.; Beltz, W. R.; Mangini, L.; Abelson, H. T.; Modest, E. J.; Frei, E., III. Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts. Biochem. Pharmacol. 29: 648-652; 1980.
21. Roy, K.; Mitsugi, K.; Sirlin, S.; Shane, B.; Sirotnak, F. M. Different antifolate-resistant L1210 cell variants with either increased or decreased folylpolyglutamate synthetase gene expression at the level of mRNA transcription. J. Biol. Chem. 270: 26918-26922; 1995.
22. Roy, K.; Egan, M. G.; Sirlin, S.; Sirotnak, F. M. Posttranscriptionally mediated decreases in folylpolyglutamate synthetase gene expression in some folate analogue-resistant variants of the L1210 cell - evidence for an altered cognate mRNA in the variants affecting the rate of de novo synthesis of the enzyme. J. Biol. Chem. 272: 6903-6908; 1997.
23. Mini, E.; Moroson, B. A.; Franco, C. T.; Bertino, J. R. Cytotoxic effects of folate antagonists against methotrcxate-resistant human leukemic lymphoblast CCRF-CEM cell lines. Cancer Res. 45: 325-330; 1985.
24. Takemura, Y.; Kobayashi, H.; Gibson, W.; Kimbell, R.; Miyachi, H.; Jackman, A. L. The influence of drug-exposure conditions on the development of resistance to methotrexate or ZD1694 in cultured human leukaemia cells. Int. J. Cancer 66: 29-36; 1996.
25. Matherly, L. H.; Angeles, S. M.; McGuire, J. J. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells characterized by severely impaired antifolate membrane transport. Biochem. Pharmacol. 46: 2185-2195; 1993.